Where? 

UK, France, Germany, Switzerland, Austria, Taiwan, Malaysia,  USA and Australia.
 

For whom? 

Companies ranging from start up (less than 10 staff) to major international companies
 

Projects

Development of stable liquid formulations of proteins

Development of Topical formulations

Optimisation and validation of lyophilisation processes for proteins

Tech transfer of lyophilised and liquid injectable products to new manufacturing sites

Review of the organisation and running of a formulation department consisting of around 50 staff, including its relationships with other departments.

Marketing of spare capacity for contract manufacturers

Interim management of Quality and Development Departments

Advising on formulation aspects to improve oral absorption of a peptide

Preparation of the Quality section of  Common Technical Documents for EU regulatory submission.

Review of inward licensing opportunities.

Some of the types of drugs developed

Proteins (Growth hormone, FSH, LH, Interleukins, Interferons,  etc)

Peptides (GRF, antifungals etc)

RNA

Anti retovirals

Antineoplastics

Recombinant protein vaccines

G.I. products

S.R. Injections